IPO in 2015 (HKSE: 1530)
IPO in 2021 (NASDAQ: AADI)
IPO in 2023 (NASDAQ: SLRN)
IPO in 2019 (NASDAQ: ADPT)
IPO in 2017 (HKSE: 1789)
Acquired by Ipsen
NASDAQ: ALPN
IPO in 2018 (NASDAQ: RCUS)
Acquired by Eli Lilly
NASDAQ: BYSI
Acquired by Becton Dickinson
IPO in 2024 (NASDAQ: CGON)
Acquired by Regeneron
Acquired by GRAIL
IPO in 2021 (NASDAQ: HLTH)
NASDAQ: EQ
IPO in 2020 (HKSE: 1952)
Acquired by Roche
Acquired by Illumina
IPO in 2016 (NASDAQ: NVTA)
Acquired by Pacific Biosciences
Acquired by Merck
Acquired by 10X Genomics
NASDAQ: SCYX
Acquired by Atricure
IPO in 2019 (SHA: 688108)
IPO in 2021 (NASDAQ: TERN)
NASDAQ: ZNTL